Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16628)
All Articles published online
|
Publishing Process of This Article
|
May 7, 2018 (publication date) through Dec 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Park SC, Jeen YT. Anti-integrin therapy for inflammatory bowel disease. World J Gastroenterol 2018; 24(17): 1868-1880 [PMID: 29740202 DOI: 10.3748/wjg.v24.i17.1868] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i17/1868.htm |
| Number | Citing Articles |
| 1 |
S. Hopkin, J.M. Lord, M. Chimen. Dysregulation of leukocyte trafficking in ageing: Causal factors and possible corrective therapies. Pharmacological Research 2021; 163: 105323 doi: 10.1016/j.phrs.2020.105323
|
| 2 |
Lei Li, Mei Zhi, Siwei Wang, Jun Deng, Qing Cai, Dayun Feng. The effect of workplace environment on coal miners' gut microbiota in a mouse model. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1453798
|
| 3 |
Yara Dadalti Fragoso. Adverse events and monitoring requirements associated with monoclonal antibody therapy in patients with multiple sclerosis. Drugs & Therapy Perspectives 2019; 35(12): 627 doi: 10.1007/s40267-019-00682-0
|
| 4 |
Tamara S. Bodnar, Amanda Chao, Parker J. Holman, Linda Ellis, Charlis Raineki, Joanne Weinberg. Impact of the COVID-19 pandemic on adults with Fetal Alcohol Spectrum Disorder: linking immune function to mental health status. Frontiers in Neuroscience 2023; 17 doi: 10.3389/fnins.2023.1214100
|
| 5 |
Yutong Wu, Qiaolin Wang, Sujie Jia, Qianjin Lu, Ming Zhao. Gut-tropic T cells and extra-intestinal autoimmune diseases. Autoimmunity Reviews 2024; 23(7-8): 103544 doi: 10.1016/j.autrev.2024.103544
|
| 6 |
Sebastian Fuchs, Nadia Sawas, Nicolas Staedler, David A. Schubert, Annalisa D'Andrea, Robert Zeiser, Luca Piali, Petr Hruz, Andreas P. Frei. High‐dimensional single‐cell proteomics analysis identifies immune checkpoint signatures and therapeutic targets in ulcerative colitis. European Journal of Immunology 2019; 49(3): 462 doi: 10.1002/eji.201847862
|
| 7 |
Emma R. Brannon, M. Valentina Guevara, Noah J. Pacifici, Jonathan K. Lee, Jamal S. Lewis, Omolola Eniola-Adefeso. Polymeric particle-based therapies for acute inflammatory diseases. Nature Reviews Materials 2022; 7(10): 796 doi: 10.1038/s41578-022-00458-5
|
| 8 |
Inès Ben Ghezala, Maëva Charkaoui, Christophe Michiels, Marc Bardou, Maxime Luu. Small Molecule Drugs in Inflammatory Bowel Diseases. Pharmaceuticals 2021; 14(7): 637 doi: 10.3390/ph14070637
|
| 9 |
Gerhard Rogler. Mechanism of action of vedolizumab: do we really understand it?. Gut 2019; 68(1): 4 doi: 10.1136/gutjnl-2018-316777
|
| 10 |
Amritpal Dhaliwal, Jonathan I. Quinlan, Kellie Overthrow, Carolyn Greig, Janet M. Lord, Matthew J. Armstrong, Sheldon C. Cooper. Sarcopenia in Inflammatory Bowel Disease: A Narrative Overview. Nutrients 2021; 13(2): 656 doi: 10.3390/nu13020656
|
| 11 |
Meitong Guo, Xiaoyan Wang. Pathological mechanism and targeted drugs of ulcerative colitis: A review. Medicine 2023; 102(37): e35020 doi: 10.1097/MD.0000000000035020
|
| 12 |
Karine Mariane Steigleder, Fernando Lopes Ponte Neto, Cristiane Kibune Nagasako, Raquel Franco Leal. Biological Therapy for Inflammatory Bowel Disease. 2020; doi: 10.5772/intechopen.90536
|
| 13 |
Rita Lauro, Federica Mannino, Natasha Irrera, Francesco Squadrito, Domenica Altavilla, Giovanni Squadrito, Giovanni Pallio, Alessandra Bitto. Pharmacogenetics of Biological Agents Used in Inflammatory Bowel Disease: A Systematic Review. Biomedicines 2021; 9(12): 1748 doi: 10.3390/biomedicines9121748
|
| 14 |
Laurie B. Grossberg, Konstantinos Papamichael, Adam S. Cheifetz. Review article: emerging drug therapies in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2022; 55(7): 789 doi: 10.1111/apt.16785
|
| 15 |
Tsvetelina Velikova, Issa El Kaouri, Konstantina Bakopoulou, Milena Gulinac, Kremena Naydenova, Martin Dimitrov, Milena Peruhova, Snezhina Lazova. Mucosal Immunity and Trained Innate Immunity of the Gut. Gastroenterology Insights 2024; 15(3): 661 doi: 10.3390/gastroent15030048
|
| 16 |
Dong Yeon Jeong, Seung Kim, Min Ji Son, Chei Yun Son, Jong Yeob Kim, Andreas Kronbichler, Keum Hwa Lee, Jae Il Shin. Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review. Autoimmunity Reviews 2019; 18(5): 439 doi: 10.1016/j.autrev.2019.03.002
|
| 17 |
Sophie Vieujean, Ferdinando D’Amico, Patrick Netter, Silvio Danese, Laurent Peyrin‐Biroulet. Landscape of new drugs and targets in inflammatory bowel disease. United European Gastroenterology Journal 2022; 10(10): 1129 doi: 10.1002/ueg2.12305
|
| 18 |
Louis Williams, Frank Cirrone, Kelli Cole, Maher Abdul-Hay, Leo Luznik, Ahmad Samer Al-Homsi. Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.00636
|
| 19 |
Emiko Mizoguchi, Daren Low, Yui Ezaki, Toshiyuki Okada. Recent updates on the basic mechanisms and pathogenesis of inflammatory bowel diseases in experimental animal models. Intestinal Research 2020; 18(2): 151 doi: 10.5217/ir.2019.09154
|
| 20 |
Natalie E. Wickenheisser, Amanda M. Craig, Jeffrey A. Kuller, Sarah K. Dotters-Katz. The Risks and Benefits of Monoclonal Antibody Therapy During Pregnancy and Postpartum: Maternal, Obstetric, and Neonatal Considerations. Obstetrical & Gynecological Survey 2023; 78(7): 429 doi: 10.1097/OGX.0000000000001155
|
| 21 |
Hiroyuki Fukase, Toshifumi Kajioka, Ichiro Oikawa, Naoki Ikeda, Hidetoshi Furuie. AJM300, a novel oral antagonist of α4‐integrin, sustains an increase in circulating lymphocytes: A randomised controlled trial in healthy male subjects. British Journal of Clinical Pharmacology 2020; 86(3): 591 doi: 10.1111/bcp.14151
|
| 22 |
Priyanka Devi, Yerramsetti Nanaji, Nikita Khanna, Ashok Kumar Yadav, Sandip V. Pawar. Probiotic Research in Therapeutics. 2021; : 85 doi: 10.1007/978-981-33-6236-9_4
|
| 23 |
Maria Rosaria Perri, Carmen Romano, Mariangela Marrelli, Ludovica Zicarelli, Claudia-Crina Toma, Daniele Basta, Filomena Conforti, Giancarlo Statti. Beneficial Role of Fruits, Their Juices, and Freeze-Dried Powders on Inflammatory Bowel Disease and Related Dysbiosis. Plants 2021; 11(1): 4 doi: 10.3390/plants11010004
|
| 24 |
Lei He, Tuo Deng, Yurong Huang, Wangliu Yang, Jie Yang, Gengqing Song. Association between 23 drugs and inflammatory bowel disease: a two-sample Mendelian randomization study. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1371362
|
| 25 |
Sherman Picardo, Cynthia H. Seow. The impact of pregnancy on biologic therapies for the treatment of inflammatory bowel disease. Best Practice & Research Clinical Gastroenterology 2020; : 101670 doi: 10.1016/j.bpg.2020.101670
|
| 26 |
Joyce J. B. C. van Beers, Jan G. M. C. Damoiseaux. Therapeutic Antibodies. Methods in Molecular Biology 2022; 2313: 27 doi: 10.1007/978-1-0716-1450-1_2
|
| 27 |
Nursyuhada Azzman. Crohn’s Disease: Potential Drugs for Modulation of Autophagy. Medicina 2019; 55(6): 224 doi: 10.3390/medicina55060224
|
| 28 |
Miri Assayag, Tahrir Obedeyah, Avraham Abutbul, Neville Berkman. The integrin receptor beta7 subunit mediates airway remodeling and hyperresponsiveness in allergen exposed mice. Respiratory Research 2024; 25(1) doi: 10.1186/s12931-024-02899-8
|
| 29 |
Elin Skott, Liu L. Yang, Miranda Stiernborg, Åsa Söderström, Joëlle Rȕegg, Martin Schalling, Yvonne Forsell, MaiBritt Giacobini, Catharina Lavebratt. Effects of a synbiotic on symptoms, and daily functioning in attention deficit hyperactivity disorder – A double-blind randomized controlled trial. Brain, Behavior, and Immunity 2020; 89: 9 doi: 10.1016/j.bbi.2020.05.056
|
| 30 |
Neha Phani Bhushan, Trevor Stack, Evan A. Scott, Kenneth R. Shull, Benjamin Mathew, Divya Bijukumar. In vitro assessment of varying peptide surface density on the suppression of angiogenesis by micelles displaying αvβ3 blocking peptides. Journal of Biomedical Materials Research Part B: Applied Biomaterials 2023; 111(2): 343 doi: 10.1002/jbm.b.35154
|
| 31 |
Roxana Nemteanu, Irina Ciortescu, Corina Elena Hincu, Andreea Clim, Liliana Gheorghe, Anca Trifan, Alina Plesa. Replacing the Burden of the Gluten Free Diet: Then, Now, and the Future. International Journal of Molecular Sciences 2022; 23(23): 15108 doi: 10.3390/ijms232315108
|
| 32 |
Yingying Liu, Ainsley M. Robinson, Xiao Qun Su, Kulmira Nurgali. Krill Oil and Its Bioactive Components as a Potential Therapy for Inflammatory Bowel Disease: Insights from In Vivo and In Vitro Studies. Biomolecules 2024; 14(4): 447 doi: 10.3390/biom14040447
|
| 33 |
Isaiah P. Schuster, Leslie Klyachman, Ramona Rajapakse, Farah Monzur. Inflammatory Bowel Disease. Clinical Gastroenterology 2021; : 89 doi: 10.1007/978-3-030-81780-0_4
|
| 34 |
Lea Gigon, Timothée Fettrelet, Shida Yousefi, Dagmar Simon, Hans‐Uwe Simon. Eosinophils from A to Z. Allergy 2023; 78(7): 1810 doi: 10.1111/all.15751
|
| 35 |
Ana Avedillo-Salas, Sara Corral-Cativiela, Ana Fanlo-Villacampa, Jorge Vicente-Romero. The Efficacy and Safety of Biologic Drugs in the Treatment of Moderate–Severe Crohn’s Disease: A Systematic Review. Pharmaceuticals 2023; 16(11): 1581 doi: 10.3390/ph16111581
|
| 36 |
Yi Liu, Benjamin Elsworth, Pau Erola, Valeriia Haberland, Gibran Hemani, Matt Lyon, Jie Zheng, Oliver Lloyd, Marina Vabistsevits, Tom R Gaunt, Robinson Peter. EpiGraphDB: a database and data mining platform for health data science. Bioinformatics 2021; 37(9): 1304 doi: 10.1093/bioinformatics/btaa961
|
| 37 |
Per M. Hellström, Eric Gemmen, Heather A. Ward, Hyewon Koo, Freddy Faccin, Zhenyi Xue, Petter Malmborg. Switching from originator infliximab to biosimilar versus continuing on originator in inflammatory bowel disease: results from the observational Project NORTH study. Scandinavian Journal of Gastroenterology 2022; 57(12): 1435 doi: 10.1080/00365521.2022.2090275
|
| 38 |
Vivian Rachel Feig, Sufeng Zhang, Ashka Patel, Bruna Santos, Ziliang Kang, Sharmeel Wasan, Ana Beloqui, Giovanni Traverso. Designing for medication adherence in inflammatory bowel disease: multi-disciplinary approaches for self-administrable biotherapeutics. eClinicalMedicine 2024; 77: 102850 doi: 10.1016/j.eclinm.2024.102850
|
| 39 |
Hua-Min Zhang, Shuo Yuan, Huan Meng, Xiao-Ting Hou, Jiao Li, Jia-Chen Xue, You Li, Qi Wang, Ji-Xing Nan, Xue-Jun Jin, Qing-Gao Zhang. Stem Cell-Based Therapies for Inflammatory Bowel Disease. International Journal of Molecular Sciences 2022; 23(15): 8494 doi: 10.3390/ijms23158494
|
| 40 |
Shashuang Zhang, Wenhua Liang, Lingjie Luo, Shan Sun, Feng Wang. The role of T cell trafficking in CTLA-4 blockade-induced gut immunopathology. BMC Biology 2020; 18(1) doi: 10.1186/s12915-020-00765-9
|
| 41 |
Badr Al-Bawardy, Raina Shivashankar, Deborah D. Proctor. Novel and Emerging Therapies for Inflammatory Bowel Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.651415
|
| 42 |
Hui Gao, Yinzheng Li, Jie Sun, Huzi Xu, Meng Wang, Xuezhi Zuo, Qiang Fu, Yanchao Guo, Zhenyan Chen, Piwei Zhang, Xudong Li, Niwen Wang, Ting Ye, Ying Yao, Felipe L. de Oliveira. Saccharomyces boulardii Ameliorates Dextran Sulfate Sodium‐Induced Ulcerative Colitis in Mice by Regulating NF‐κB and Nrf2 Signaling Pathways. Oxidative Medicine and Cellular Longevity 2021; 2021(1) doi: 10.1155/2021/1622375
|
| 43 |
Shaker A. Mousa, Paul J. Davis. Encyclopedia of Molecular Pharmacology. 2021; : 174 doi: 10.1007/978-3-030-57401-7_81
|
| 44 |
Sherman Picardo, Cynthia H. Seow. A Pharmacological Approach to Managing Inflammatory Bowel Disease During Conception, Pregnancy and Breastfeeding: Biologic and Oral Small Molecule Therapy. Drugs 2019; 79(10): 1053 doi: 10.1007/s40265-019-01141-w
|
| 45 |
Eun-Ah Cho, Pingfeng Zhang, Vikas Kumar, Mikhail Kavalchuk, Hao Zhang, Qingqiu Huang, James S. Duncan, Jinhua Wu. Phosphorylation of RIAM by src promotes integrin activation by unmasking the PH domain of RIAM. Structure 2021; 29(4): 320 doi: 10.1016/j.str.2020.11.011
|
| 46 |
Lakshmikanthan Hemajha, Simran Singh, Catherin Ann Biji, Akshad Balde, Soottawat Benjakul, Rasool Abdul Nazeer. A review on inflammation modulating venom proteins/peptide therapeutics and their delivery strategies: A review. International Immunopharmacology 2024; 142: 113130 doi: 10.1016/j.intimp.2024.113130
|
| 47 |
Elisabetta Antonelli, Vincenzo Villanacci, Gabrio Bassotti. Novel oral-targeted therapies for mucosal healing in ulcerative colitis. World Journal of Gastroenterology 2018; 24(47): 5322-5330 doi: 10.3748/wjg.v24.i47.5322
|
| 48 |
Xiong Zhao, Shuai Wu, Sheng Ni, Yuan Zhong, Xian Qin, Kun Zhang, Kai Qu, Li Zhu, Wei Wu. Tannic Acid-Based Biomimetic Nanomedicine with Pathological Reactive Oxygen Species-Responsive Cargo Release for Relieving Inflammation in Rheumatoid Arthritis. ACS Applied Materials & Interfaces 2024; 16(44): 59789 doi: 10.1021/acsami.4c11494
|
| 49 |
Jiannan Li, Ren Mao, Satya Kurada, Jie Wang, Sinan Lin, Jyotsna Chandra, Florian Rieder. Pathogenesis of fibrostenosing Crohn's disease. Translational Research 2019; 209: 39 doi: 10.1016/j.trsl.2019.03.005
|
| 50 |
Elizabeth F. Snyder, Stephanie Davis, Kristina Aldrich, Manjakkollai Veerabagu, Tiziana Larussa, Ludovico Abenavoli, Luigi Boccuto. Crohn disease. The Nurse Practitioner 2021; 46(12): 22 doi: 10.1097/01.NPR.0000798212.61425.4f
|
| 51 |
Lu Chen, Guangcong Ruan, Yi Cheng, Ailin Yi, Dongfeng Chen, Yanling Wei. The role of Th17 cells in inflammatory bowel disease and the research progress. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1055914
|
| 52 |
Katharina M Scheurlen, Mary A Parks, Anne Macleod, Susan Galandiuk. Unmet Challenges in Patients with Crohn’s Disease. Journal of Clinical Medicine 2023; 12(17): 5595 doi: 10.3390/jcm12175595
|
| 53 |
Souradeep Banerjee, Ritika Nara, Soham Chakraborty, Debojyoti Chowdhury, Shubhasis Haldar. Integrin Regulated Autoimmune Disorders: Understanding the Role of Mechanical Force in Autoimmunity. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.852878
|
| 54 |
Ido Veisman, Oranit Barzilay, Liora Bruckmayer, Ola Haj-Natour, Uri Kopylov, Rami Eliakim, Shomron Ben-Horin, Bella Ungar. Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study. Journal of Clinical Medicine 2021; 10(18): 4265 doi: 10.3390/jcm10184265
|
| 55 |
Lorena Ortega Moreno, Samuel Fernández-Tomé, Raquel Abalo. Biological Treatments in Inflammatory Bowel Disease: A Complex Mix of Mechanisms and Actions. Biologics 2021; 1(2): 189 doi: 10.3390/biologics1020012
|
| 56 |
Shiba Prasad Dash, Saloni Gupta, Pranita P. Sarangi. Monocytes and macrophages: Origin, homing, differentiation, and functionality during inflammation. Heliyon 2024; 10(8): e29686 doi: 10.1016/j.heliyon.2024.e29686
|
| 57 |
Aejaz Ahmed, Khurshid I. Molvi, Harun M. Patel, Riaz Ullah, Ahmed Bari. Synthesis of novel 2, 3, 5-tri-substituted thiazoles with anti-inflammatory and antibacterial effect causing clinical pathogens. Journal of Infection and Public Health 2020; 13(4): 472 doi: 10.1016/j.jiph.2020.02.002
|
| 58 |
Stacey Rolak, Sunanda V. Kane. Conventional Therapies for Crohn's Disease. Gastroenterology Clinics of North America 2022; 51(2): 271 doi: 10.1016/j.gtc.2021.12.004
|
| 59 |
Yasaswi Gayatri Mishra, Bramanandam Manavathi. Focal adhesion dynamics in cellular function and disease. Cellular Signalling 2021; 85: 110046 doi: 10.1016/j.cellsig.2021.110046
|
| 60 |
Akshay Patel, Andras Perl. Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity. Antioxidants & Redox Signaling 2022; 36(7-9): 367 doi: 10.1089/ars.2021.0068
|
| 61 |
Cristiano Pagnini, Theresa T. Pizarro, Fabio Cominelli. Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00671
|
| 62 |
Toshio Arai, Fernando Lopes. Potential of human helminth therapy for resolution of inflammatory bowel disease: The future ahead. Experimental Parasitology 2022; 232: 108189 doi: 10.1016/j.exppara.2021.108189
|
| 63 |
Meng‐xi Xiu, Yuan‐meng Liu, Wen‐jun Wang. Investigation of hub genes and immune status in heart transplant rejection using endomyocardial biopsies. Journal of Cellular and Molecular Medicine 2021; 25(2): 763 doi: 10.1111/jcmm.16127
|
| 64 |
Yuehong Chen, Huan Liu, Qiuping Zhang, Yubin Luo, Liang Wu, Yutong Zhong, Zhigang Tang, Yaoyu Pu, Chenyang Lu, Geng Yin, Qibing Xie. Cinacalcet Targets the Neurokinin-1 Receptor and Inhibits PKCδ/ERK/P65 Signaling to Alleviate Dextran Sulfate Sodium-Induced Colitis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.735194
|
| 65 |
Nasar Aslam, Sheng Wei Lo, Rafid Sikafi, Tom Barnes, Jonathan Segal, Philip J Smith, Jimmy K Limdi. A review of the therapeutic management of ulcerative colitis. Therapeutic Advances in Gastroenterology 2022; 15 doi: 10.1177/17562848221138160
|
| 66 |
Hiroyuki Fukase, Toshifumi Kajioka, Ichiro Oikawa, Naoki Ikeda, Hidetoshi Furuie. Food Effect on a Single High Dose of Carotegrast Methyl, an Oral Antagonist of α4-Integrin, in Healthy Male Subjects: A Randomised, Placebo-Controlled, Double-Blind Study. Clinical Drug Investigation 2020; 40(3): 237 doi: 10.1007/s40261-019-00879-1
|
| 67 |
Olga Hartwig, Brigitta Loretz, Adrien Nougarede, Dorothée Jary, Eric Sulpice, Xavier Gidrol, Fabrice Navarro, Claus-Michael Lehr. Leaky gut model of the human intestinal mucosa for testing siRNA-based nanomedicine targeting JAK1. Journal of Controlled Release 2022; 345: 646 doi: 10.1016/j.jconrel.2022.03.037
|
| 68 |
Marcello Candelli, Laura Franza, Giulia Pignataro, Veronica Ojetti, Marcello Covino, Andrea Piccioni, Antonio Gasbarrini, Francesco Franceschi. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2021; 22(12): 6242 doi: 10.3390/ijms22126242
|
| 69 |
The treatment of inflammatory bowel disease with monoclonal antibodies in Asia. Biomedicine & Pharmacotherapy 2023; 157: 114081 doi: 10.1016/j.biopha.2022.114081
|
| 70 |
Si-Nan Lin, Ren Mao, Chenchen Qian, Dominik Bettenworth, Jie Wang, Jiannan Li, David H. Bruining, Vipul Jairath, Brian G. Feagan, Min-Hu Chen, Florian Rieder. Development of antifibrotic therapy for stricturing Crohn’s disease: lessons from randomized trials in other fibrotic diseases. Physiological Reviews 2022; 102(2): 605 doi: 10.1152/physrev.00005.2021
|
| 71 |
Roberto Catanzaro, Francesco Marotta, Azam Yazdani, Morena Sciuto. Inflammatory Bowel Disease Therapies and Acute Liver Injury. Toxics 2024; 12(6): 421 doi: 10.3390/toxics12060421
|
| 72 |
Ema Saltović, Brankica Mijandrušić-Sinčić, Alen Braut, Ivana Škrobonja, Ella Sever, Irena Glažar, Sonja Pezelj-Ribarić, Miranda Muhvić-Urek. Absence of Oral Opportunistic Infections in Patients with Inflammatory Bowel Disease Receiving Anti-TNF-α and Anti-Integrin-α4β7 Therapy. Dentistry Journal 2022; 10(3): 32 doi: 10.3390/dj10030032
|
| 73 |
Yating Niu, Jun Zhang, Dianhua Shi, Weibiao Zang, Jianguo Niu. Glycosides as Potential Medicinal Components for Ulcerative Colitis: A Review. Molecules 2023; 28(13): 5210 doi: 10.3390/molecules28135210
|
| 74 |
Mariana Ferreira-Duarte, Joana Beatriz Sousa, Carmen Diniz, Teresa Sousa, Margarida Duarte-Araújo, Manuela Morato. Experimental and Clinical Evidence of Endothelial Dysfunction in Inflammatory Bowel Disease. Current Pharmaceutical Design 2020; 26(30): 3733 doi: 10.2174/1381612826666200701212414
|
| 75 |
Ivan Voitalov, Lixia Zhang, Casey Kilpatrick, Johanna B. Withers, Alif Saleh, Viatcheslav R. Akmaev, Susan Dina Ghiassian. The module triad: a novel network biology approach to utilize patients’ multi-omics data for target discovery in ulcerative colitis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-26276-x
|
| 76 |
Antonio D’Ambrosio, Annamaria Altomare, Tamara Boscarino, Manuele Gori, Paola Balestrieri, Lorenza Putignani, Federica Del Chierico, Simone Carotti, Michele Cicala, Michele Pier Luca Guarino, Vincenzo Piemonte. Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients. Bioengineering 2024; 11(7): 710 doi: 10.3390/bioengineering11070710
|
| 77 |
Lacey DeVreese, Cynthia Tsien, Sanjay K. Murthy. Encyclopedia of Gastroenterology. 2020; : 248 doi: 10.1016/B978-0-12-801238-3.65640-4
|
| 78 |
Min-Jing Chang, Jia-Wei Hao, Jun Qiao, Miao-Ran Chen, Qian Wang, Qi Wang, Sheng-Xiao Zhang, Qi Yu, Pei-Feng He. A Compendium of Mucosal Molecular Characteristics Provides Novel Perspectives on the Treatment of Ulcerative Colitis. Journal of Crohn's and Colitis 2023; 17(6): 909 doi: 10.1093/ecco-jcc/jjad011
|
| 79 |
Byong Duk Ye, Jae Hee Cheon, Ki Hwan Song, Joo Sung Kim, Young-Ho Kim, Hyuk Yoon, Kang-Moon Lee, Sang-Bum Kang, Byung Ik Jang, Jae Jun Park, Tae Oh Kim, Dae-Wook Lee, Chee Yoong Foo, Jeong Eun Shin, Dong Il Park. The real-world outcomes of vedolizumab in patients with ulcerative colitis in Korea: a multicenter retrospective study. Therapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/17562848211024769
|
| 80 |
Nakisha S. Rutledge, William A. Muller. Understanding Molecules that Mediate Leukocyte Extravasation. Current Pathobiology Reports 2020; 8(2): 25 doi: 10.1007/s40139-020-00207-9
|
| 81 |
Danielle Nader, Gerard F. Curley, Steven W. Kerrigan. A new perspective in sepsis treatment: could RGD-dependent integrins be novel targets?. Drug Discovery Today 2020; 25(12): 2317 doi: 10.1016/j.drudis.2020.09.038
|
| 82 |
Alberto Signore, Rita Bonfiglio, Michela Varani, Filippo Galli, Giuseppe Campagna, Manuel Desco, Lorena Cussó, Maurizio Mattei, Andreas Wunder, Filippo Borri, Maria T. Lupo, Elena Bonanno. Radioimmune Imaging of α4β7 Integrin and TNFα for Diagnostic and Therapeutic Applications in Inflammatory Bowel Disease. Pharmaceutics 2023; 15(3): 817 doi: 10.3390/pharmaceutics15030817
|
| 83 |
Yuta Kinoshita, Seiya Arita, Haruka Murazoe, Kazuo Kitamura, Shinya Ashizuka, Kyoko Inagaki-Ohara. Subcutaneously administered adrenomedullin exerts a potent therapeutic effect in a murine model of ulcerative colitis. Human Cell 2019; 32(1): 12 doi: 10.1007/s13577-018-0219-9
|
| 84 |
Laura Golusda, Anja A Kühl, Britta Siegmund, Daniela Paclik. Reducing Pain in Experimental Models of Intestinal Inflammation Affects the Immune Response. Inflammatory Bowel Diseases 2022; 28(5): 801 doi: 10.1093/ibd/izab290
|
| 85 |
Nathalie Britzen-Laurent, Carl Weidinger, Michael Stürzl. Contribution of Blood Vessel Activation, Remodeling and Barrier Function to Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2023; 24(6): 5517 doi: 10.3390/ijms24065517
|
| 86 |
Nariman Hossein-Javaheri, Michael Youssef, Yaanu Jeyakumar, Vivian Huang, Parul Tandon. The Management of Inflammatory Bowel Disease during Reproductive Years: An Updated Narrative Review. Reproductive Medicine 2023; 4(3): 180 doi: 10.3390/reprodmed4030017
|
| 87 |
Jung Won Lee, Chang Soo Eun. Inflammatory bowel disease in Korea: epidemiology and pathophysiology. The Korean Journal of Internal Medicine 2022; 37(5): 885 doi: 10.3904/kjim.2022.138
|
| 88 |
Nikhil Sharma, Pavit Tewatia, Philip R. Harvey, Aditi Kumar. Controversies in Venous Thromboembolism Risk Assessment in Inflammatory Bowel Disease: A Narrative Review. Diagnostics 2024; 14(19): 2112 doi: 10.3390/diagnostics14192112
|